CEMEX (NYSE:CX) Sets New 52-Week Low at $5.66

CEMEX, S.A.B. de C.V. (NYSE:CX - Get Free Report)'s stock price reached a new 52-week low on Friday . The stock traded as low as $5.66 and last traded at $5.66, with a volume of 5116879 shares changing hands. The stock had previously closed at $5.84.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on CX shares. StockNews.com raised CEMEX from a "buy" rating to a "strong-buy" rating in a research report on Thursday, July 18th. JPMorgan Chase & Co. reaffirmed an "overweight" rating and set a $8.00 price target on shares of CEMEX in a research report on Wednesday, August 21st. The Goldman Sachs Group assumed coverage on CEMEX in a research report on Wednesday, July 10th. They issued a "buy" rating and a $9.00 target price on the stock. Barclays raised CEMEX from an "equal weight" rating to an "overweight" rating and set a $9.00 target price on the stock in a research report on Wednesday, July 31st. Finally, Royal Bank of Canada began coverage on CEMEX in a research report on Tuesday, May 14th. They issued an "underperform" rating and a $9.00 target price on the stock. One research analyst has rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, CEMEX has an average rating of "Moderate Buy" and a consensus target price of $8.70.

CEMEX Trading Down 2.7 %

The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.65 and a current ratio of 0.90. The stock has a market capitalization of $8.24 billion, a price-to-earnings ratio of 40.61 and a beta of 1.47. The business has a fifty day simple moving average of $6.32 and a 200 day simple moving average of $7.29.

CEMEX (NYSE:CX - Get Free Report) last announced its earnings results on Thursday, July 25th. The construction company reported $0.17 earnings per share (EPS) for the quarter. The company had revenue of $4.49 billion during the quarter. CEMEX had a net margin of 1.05% and a return on equity of 1.66%. As a group, research analysts expect that CEMEX, S.A.B. de C.V. will post 0.84 EPS for the current year.

CEMEX Cuts Dividend

The company also recently disclosed a Variable dividend, which will be paid on Tuesday, September 24th. Investors of record on Friday, September 13th will be given a dividend of $0.021 per share. The ex-dividend date is Friday, September 13th. This represents a yield of 0.7%. CEMEX's dividend payout ratio is 14.29%.

Institutional Investors Weigh In On CEMEX

Several institutional investors and hedge funds have recently bought and sold shares of CX. CWM LLC raised its stake in CEMEX by 75.0% during the first quarter. CWM LLC now owns 3,514 shares of the construction company's stock worth $32,000 after acquiring an additional 1,506 shares in the last quarter. Ashton Thomas Private Wealth LLC acquired a new position in CEMEX during the second quarter worth about $33,000. Thoroughbred Financial Services LLC acquired a new position in CEMEX during the second quarter worth about $81,000. Fisher Asset Management LLC increased its stake in shares of CEMEX by 3,180.2% in the fourth quarter. Fisher Asset Management LLC now owns 10,923 shares of the construction company's stock valued at $85,000 after buying an additional 10,590 shares during the period. Finally, Prudent Man Advisors LLC acquired a new position in shares of CEMEX in the fourth quarter valued at approximately $86,000. Institutional investors own 82.97% of the company's stock.

About CEMEX

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services worldwide. The company offers gray ordinary portland, white portland, oil-well, and blended cement products; mortar; and standard ready-mix, architectural and decorative, rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial, and other concrete products.